Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations

Graefes Arch Clin Exp Ophthalmol. 2019 Mar;257(3):447-452. doi: 10.1007/s00417-018-04209-7. Epub 2018 Dec 13.

Abstract

Interferons are cytokines that regulate the host's response to viral infection, particularly in the setting of the immunologic response to the hepatitis C virus (HCV). While the virus has the ability to evade the host's innate and specific immunity, exogenous interferon-α with combined ribavirin, treatments have been found to achieve a significant sustained viral response in subgroups of patients with chronic HCV. One of the major side effects of interferon-α is an ocular retinopathy characterized by flame-shaped hemorrhages and cotton wool spots visualized on funduscopic examination. There have been documented cases of more severe side effects including optic nerve and retinal artery damage; however, these instances are the minority. We sought to investigate the literature surrounding interferon-induced retinopathy, clinically correlate our findings with two recent cases, and provide recommendations for practitioners who continue to manage chronic HCV patients using interferon-α with combined ribavirin treatments.

Keywords: Fundoscopic imaging; Hepatitis C; Interferon; Macular edema; Neuropathy; Ocular toxicity; Optical coherence tomography; Retinopathy.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon-alpha / adverse effects*
  • Interferon-alpha / therapeutic use
  • Practice Guidelines as Topic*
  • Retina / drug effects
  • Retina / pathology
  • Retinal Diseases / chemically induced*
  • Retinal Diseases / diagnosis
  • Tomography, Optical Coherence

Substances

  • Antiviral Agents
  • Interferon-alpha